Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 19, 2005
J Am Soc Nephrol 16: 3721-3727, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005010006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005010006v1
16/12/3721    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seliger, S. L.
Right arrow Articles by Siscovick, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seliger, S. L.
Right arrow Articles by Siscovick, D. S.

Epidemiology and Outcomes

Cystatin C and Subclinical Brain Infarction

Stephen L. Seliger*, W.T. Longstreth, Jr{dagger}, Ronit Katz{ddagger}, Teri Manolio§, Linda F. Fried||, Michael Shlipak, Catherine O. Stehman-Breen#, Anne Newman**, Mark Sarnak{dagger}{dagger}, Daniel L. Gillen{ddagger}{ddagger}, Anthony Bleyer§§ and David S. Siscovick||||

* Division of Nephrology, University of Maryland, Baltimore, Maryland; Departments of {dagger} Neurology, {ddagger} Biostatistics, and |||| Epidemiology and Medicine, University of Washington, Seattle, Washington; § Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Maryland; || Division of Nephrology, Pittsburgh VA Medical Center, Pittsburgh, Pennsylvania; Division of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California; # Amgen, Inc., Thousand Oaks, California; ** Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; {dagger}{dagger} Division of Nephrology, New England Medical Center, Boston, Massachusetts; {ddagger}{ddagger} Department of Health Studies, University of Chicago, Chicago, Illinois; and §§ Division of Nephrology, Wake Forest University, Winston-Salem, North Carolina

Address correspondence to: Dr. Stephen Seliger, University of Maryland, N3W143, 22 S. Greene Street, Baltimore, MD 21201. Phone: 410-328-5720; Fax: 410-328-2718; E-mail: sseliger{at}medicine.umaryland.edu

Received for publication January 3, 2005. Accepted for publication August 23, 2005.

Subclinical brain infarcts (SBI) are common in the elderly and are associated with covert neurologic and cognitive impairment. Although renal impairment is associated with accelerated cerebrovascular disease and an increased risk for clinically apparent brain infarct, few studies have examined the relationship between renal function and SBI, and these may have been limited by the inaccuracy of creatinine as a renal function marker. A cross-sectional study was performed among older adults in the Cardiovascular Health Study to examine associations between SBI and two serum markers of renal function: Serum creatinine (SCr) and cystatin C (CysC). Patients had cranial magnetic resonance imaging and renal markers measured in 1992 to 1993. Logistic regression was used to estimate the associations between renal function (estimated by 1/SCr and 1/CysC) and SBI, controlling for potential confounding factors. SBI were present in 789 (28.7%) of 2784 participants. A linear association with SBI was observed for 1/CysC (per 1-SD decrement; odds ratio [OR] 1.20; 95% confidence interval [CI] 1.09 to 1.32; P < 0.001) but not for 1/SCr (OR 1.08; 95% CI 0.98 to 1.19; P = 0.14), for which a quadratic U-shaped association was suggested (P = 0.004). In a model with both markers, 1/CysC was linearly associated with SBI (OR 1.26; P < 0.001), whereas 1/SCr was not (OR 1.06; P = 0.3). The prevalence of SBI was directly associated with quintile of CysC, whereas the association between SCr and SBI was U-shaped, with greater prevalence at high and low levels. Compared with creatinine, CysC, a novel marker of renal function, has a stronger and more direct association with SBI in the elderly.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, and K. N. Vemmos
Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality
Nephrol. Dial. Transplant., January 1, 2009; 24(1): 194 - 200.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. L. Seliger and W.T. Longstreth Jr
Lessons About Brain Vascular Disease From Another Pulsating Organ, the Kidney
Stroke, January 1, 2008; 39(1): 5 - 6.
[Full Text] [PDF]


Home page
StrokeHome page
M. A. Ikram, M. W. Vernooij, A. Hofman, W. J. Niessen, A. van der Lugt, and M. M.B. Breteler
Kidney Function Is Related to Cerebral Small Vessel Disease
Stroke, January 1, 2008; 39(1): 55 - 61.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP